Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the Erythropoietin in Myocardial Infarction Trial

This publication has 28 references indexed in Scilit:

• Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction
  JAMA, 2011
• Erythropoietin in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
  Circulation: Cardiovascular Interventions, 2010
• Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations
  Basic Research in Cardiology, 2010
• A single dose of erythropoietin in ST-elevation myocardial infarction
  European Heart Journal, 2010
• Speckle tracking imaging improves in vivo assessment of EPO-induced myocardial salvage early after ischemia-reperfusion in rats
  American Journal of Physiology-Heart and Circulatory Physiology, 2010
• Single-Dose Intravenous Administration of Recombinant Human Erythropoietin Is a Promising Treatment for Patients With Acute Myocardial Infarction
  Circulation Journal, 2010
• Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection
  Proceedings of the National Academy of Sciences, 2009
• Myocardial Reperfusion Injury
  New England Journal of Medicine, 2007
• A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study
  Cardiovascular Drugs and Therapy, 2006
• Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury
  Circulation, 2003